Evidence map›Paper›PMID 31778467›Full record

ArticleEinstein (Sao Paulo, Brazil)2020

Loss of tolerance 5 days after discontinuing sulphonamide introduced via desensitization in delayed reaction.

Amanda Rocha Firmino Pereira, Marcelo Vivolo Aun, Nathália Coelho Portilho Kelmann, Antônio Abílio Motta, Jorge Kalil, Pedro Giavina-Bianchi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Amanda Rocha Firmino PereiraHospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0003-1536-5291
Marcelo Vivolo AunFaculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, SP, Brazil.ORCID 0000-0001-9882-5200
Nathália Coelho Portilho KelmannFaculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0003-1912-4049
Antônio Abílio MottaFaculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0003-0276-3362
Jorge KalilFaculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0001-8415-4274
Pedro Giavina-BianchiFaculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-1034-7580
Universidade de São Paulo · BRHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fixed drug eruption is a non-immediate hypersensitivity reaction to drug, characterized by recurrent erythematous or violaceous, rounded, well-defined border plaques, which always appear in the same location every time the culprit drug is administered. The usual practice is to avoid the drug involved and to use a structurally different drug. However, there are situations in which there is no safe and effective therapy. In such situations, desensitization is the only option. We describe the case of a patient who presented fixed eruption due to sulfamethoxazole-trimethoprim, who underwent successful desensitization, but required a repeat procedure twice due to relapse after inadvertent full-dose reintroduction. In non-immediate hypersensitivity reaction to drug, the indication is controversial and there is no technical standardization. Furthermore, the time at which such tolerance is lost after discontinuing the drug involved is unknown. In severe non-immediate reactions of types II and III, desensitization is contraindicated. The patient underwent desensitisation to sulfamethoxazole-trimethoprim three times - the first with recurrence of lesions and the second and third without manifestations, all concluded successfully and with no premedication.

Indexed as

AgedDesensitization, ImmunologicDrug EruptionsDrug HypersensitivityHumansMaleSulfamethoxazoleTrimethoprimTrimethoprim, Sulfamethoxazole Drug CombinationSulfamethoxazoleTrimethoprimTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID31778467
PMCPMC6896605
OpenAlexW2986516653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.